| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 03/22/2007 | US20070065445 Novel cyclooxygenase variants and methods of use |
| 03/22/2007 | US20070065439 Antibodies against interleukin-1 beta |
| 03/22/2007 | US20070065435 Gamma-1 And Gamma-3 Anti-Human CD23 Monoclonal Antibodies And Use Thereof As Therapeutics |
| 03/22/2007 | US20070065434 Gamma-1 And Gamma-3 Anti-Human CD23 Monoclonal Antibodies And Use Thereof As Therapeutics |
| 03/22/2007 | US20070065431 A polynucleotide encoding a monomeric non-antibody ligand having a loop partly modified or replaced by or amino acid(s); improved solubility; medical diagnosis; targets of drugs, steroids, pesticides, antigens, growth factors, tumour markers, cell surface proteins or viral coat proteins |
| 03/22/2007 | US20070065425 Anti-idiotypic antibody neutralizing the inhibitor activity of a factor viii inhibitor antibody |
| 03/22/2007 | US20070065424 Rationally designed polysaccharide lyases derived from chondroitinase B |
| 03/22/2007 | US20070065410 E4 or F4 and Bcl-2 peptides of small dimension (less than 30 amino acids) that bind a PP2A holoenzyme or one of its sub-units, particularly useful as anticancer, antiviral and antiparasitic agents |
| 03/22/2007 | US20070065408 Modified polypeptides for targeting cell-entry of the adenoviruses of subtype b |
| 03/22/2007 | US20070065407 Interferon-Alpha Polypeptides and Conjugates |
| 03/22/2007 | US20070065406 Homogeneous preparations of IL-28 and IL-29 |
| 03/22/2007 | CA2621344A1 Cleavage of precursors of insulins by a variant of trypsin |
| 03/21/2007 | EP1764413A1 Protein preparation containing s1-5 |
| 03/21/2007 | EP1461359B1 Novel anti-igf-ir antibodies and uses thereof |
| 03/21/2007 | EP1397492B1 Modified and stabilized gdf propeptides and uses thereof |
| 03/21/2007 | EP1341899B9 Bacterial host strains |
| 03/21/2007 | EP1339735B1 Method for preparing tryptophan rich peptides |
| 03/21/2007 | EP1313771B1 Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of haemophilus influenzae infections |
| 03/21/2007 | EP1252291B1 Flavobacterium heparinum expression system |
| 03/21/2007 | EP1216259B1 Signal sequences for the production of leu-hirudine via secretion by e. coli in a culture medium |
| 03/21/2007 | EP1100513B1 Method for producing autoinducer synthase |
| 03/21/2007 | EP1049717B1 Antibodies against human il-12 |
| 03/21/2007 | EP0950107B1 Novel nucleic acid molecules from maize and their use for the production of modified starch |
| 03/21/2007 | EP0929680B1 Thermostable dna polymerase from carboxydothermus hydrogenoformans |
| 03/21/2007 | EP0917568B1 Method for producing complex multienzymatical, storage resistant reaction mixtures and use thereof |
| 03/21/2007 | EP0902839B1 Method for inhibiting adenylosuccinate synthetase activity methylthioadenosine phosphorylase deficient cells |
| 03/21/2007 | EP0574461B9 High affinity humanized monoclonal antibodies |
| 03/21/2007 | CN1934276A Protein expression yield enhancement in cell-free protein synthesis systems by addition of antifoam agents |
| 03/21/2007 | CN1934266A Anti-myostatin antibodies |
| 03/21/2007 | CN1934258A Exo-endo cellulase fusion protein |
| 03/21/2007 | CN1934133A Anti-influenza type A virus monoclonal antibody and immunoassay instrument using the antibody |
| 03/21/2007 | CN1934128A Process for producing human serum albumin by heating in presence of divalent cation |
| 03/21/2007 | CN1932028A Plasma small peptide producing process |
| 03/21/2007 | CN1932027A Double enzyme hydrolysis process for preparing soybean peptide without bitter |
| 03/21/2007 | CN1306272C In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells |
| 03/21/2007 | CN1306036C Method for preparing interferon of white blood cells of dogs |
| 03/21/2007 | CN1306032C Coding gene of interleukin 10 and its expression method in bacillus coli |
| 03/21/2007 | CN1306031C Novel natural antibacterial peptide Hippocampusin and its preparation and application |
| 03/21/2007 | CN1306030C Human interleukin-10 gene sequenc and E coli containing the said gene sequence |
| 03/21/2007 | CN1306025C Culture medium its rpeparation method and method for culturing lact-streptocin |
| 03/20/2007 | US7193065 activated haptens useful for generating immunogens to HIV protease inhibitors |
| 03/20/2007 | US7193064 antibody or a functional fragment thereof that recognizes a human CD40 antigen present on the surface of human B cells, dendritic cells |
| 03/20/2007 | US7193063 Antibodies to a polypeptide encoded by a nucleic acid overexpressed in esophageal tumor, normal stomach and melanoma |
| 03/20/2007 | US7193058 Monoclonal antibody which recognizes membrane glycoprotein (ULBP) for use in treatment and prevention of cell proliferative disorders; immunotherapy |
| 03/20/2007 | US7193051 Ligand polypeptide for identifying modulators for treatment of nervous system disorders, schizophrenia and arthritis |
| 03/20/2007 | US7193033 Peptide having appetite stimulating activity |
| 03/20/2007 | US7192767 Matrix reactor and a method for producing products in said reactor |
| 03/20/2007 | US7192762 nucleic acid fragment isolated from fungi, that code for transferase enzymes, used in the manufacture of oils enriched in omega fatty acids in microorganisms such as algae, bacteria, fungi or yeasts; genetic engineering |
| 03/20/2007 | US7192754 Nomuraeae rileyi-origin ecdysteroid 22-oxidase and molt hormone inactivation system with the use of the same |
| 03/20/2007 | US7192753 Modified threonine deaminase |
| 03/20/2007 | US7192749 Use of the repressor glxR for the synthesis of lysine in Corynebacterium glutamicum |
| 03/20/2007 | US7192743 applying solutions comprising culture broths containing teicoplanin, from Actinoplanes teichomyceticus strains capable of producing teicoplanin, to porous adsorption resins, then eluting, treating with activated carbon to recover the teicoplanin andultrafiltration; purification |
| 03/20/2007 | US7192742 Prepared by culturing Beauveria in medium; substances thus obtained are less toxic, specifically inhibit acyl-Coenzyme A: cholesterol acyltransferase, and inhibit formation of oil droplets in macrophages |
| 03/20/2007 | US7192741 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using such DNA sequences |
| 03/20/2007 | US7192740 Recombinant viral nucleic acids |
| 03/20/2007 | US7192739 Ligand-dependent protein splicing |
| 03/20/2007 | US7192738 IGF binding proteins |
| 03/20/2007 | US7192737 Producing subunits of multimeric protein for use in gene therapy |
| 03/20/2007 | US7192736 Nucleic acid molecules encoding cytotoxic conjugates that contain a chemokine receptor targeting agent |
| 03/20/2007 | US7192735 Phosphopantetheinyl transferases and uses thereof |
| 03/20/2007 | US7192730 Comprises nucleotide sequences coding serine protease for use as tool in proteolysis, food processing and waste removal |
| 03/20/2007 | US7192718 Binds to Osteoclastogenesis Inhibitory Factor (OCIF) binding molecule (OBM) |
| 03/20/2007 | US7192712 used as the internal standard in gene expression analysis |
| 03/20/2007 | US7192706 Growth regulating proteins |
| 03/20/2007 | US7192705 Nucleotide sequences coding transmembrane cochlear-expressed gene 1(TDC1) protein for use in diagnosis, prognosis and treatment of hearing loss |
| 03/20/2007 | US7192596 Recombinant toxin fragments |
| 03/20/2007 | US7192589 Treatment of inflammatory disorders with STIgMA immunoadhesins |
| 03/20/2007 | US7192587 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/20/2007 | US7192583 Transforming growth factor binding proteins; fusion proteins; knockout animal models; for treatment of osteoporosis/ fractures |
| 03/20/2007 | US7192582 Human monoclonal antibodies to FC alpha receptor (CD89) |
| 03/20/2007 | US7192579 Retina specific; drug screening; for treating age-related macular degeneration |
| 03/20/2007 | US7192578 By administering antiinflammatory drugs |
| 03/20/2007 | CA2204266C Purified papillomavirus proteins |
| 03/20/2007 | CA2002868C Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors |
| 03/19/2007 | CA2610103A1 Clostridial toxin activatable clostridial toxins |
| 03/15/2007 | WO2007030834A1 Chimeric hcn channels |
| 03/15/2007 | WO2007030573A2 Polypeptides useful for molecular weight determinations |
| 03/15/2007 | WO2007030548A2 Identification of useful bacteriophage |
| 03/15/2007 | WO2007030451A2 Antibodies as t cell receptor mimics, methods of production and uses thereof |
| 03/15/2007 | WO2007029712A1 Promoter for introducing gene into lymphocyte or blood cell and application thereof |
| 03/15/2007 | WO2007029360A1 Bacmid variant, method of producing the same and method of producing target protein by using the same |
| 03/15/2007 | WO2007029003A2 Method of preparing a hydrogel |
| 03/15/2007 | WO2007028573A1 Tumor-associated peptides binding to human leukocyte antigen (hla) class i or ii molecules and related anti-cancer vaccine |
| 03/15/2007 | WO2006135493A3 A composition for wound healing and use thereof |
| 03/15/2007 | WO2006123157A3 Nematistatic protein |
| 03/15/2007 | WO2006104536A3 Polynucleotides encoding stem cell factor-like proteins |
| 03/15/2007 | WO2006088951A3 Cd38 modulated chemotaxis |
| 03/15/2007 | WO2006005757A3 Blood pressure lowering oligopeptides |
| 03/15/2007 | WO2004103295A3 Interleukin-9 antagonist muteins and their pharmacological methods of use |
| 03/15/2007 | WO2004072100A3 Nell peptide expression systems and bone formation activity of nell peptide |
| 03/15/2007 | WO2003093432A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 03/15/2007 | US20070061906 Human T2R75 taste receptor and related assays for identifying human bitter taste modulators |
| 03/15/2007 | US20070061905 screening mammalian chemosensory G Protein-Coupled Receptors active in taste signaling; genes and cDNA encoding such receptors |
| 03/15/2007 | US20070061904 Human T2R65 taste receptor and related assays for identifying human bitter taste modulators |
| 03/15/2007 | US20070061902 nucleic acid molecule coding for g protein-coupled recept for use in identifying modulators of taste transductance; artificial sweetners; used as additives in foods, beverages and medicinals for blocking bitter taste |
| 03/15/2007 | US20070061901 Methods to inhibit growth of prostate cancer cells |
| 03/15/2007 | US20070061900 Methods of modifying eukaryotic cells |
| 03/15/2007 | US20070060743 For diagnostics, forensics, gene mapping; identification of mutations responsible for genetic disorders or other traits, to assess biodiversity, and to produce many other types of data and products dependent on DNA and amino acid sequences |
| 03/15/2007 | US20070060742 for new human tumor necrosis factor receptor designated as Ztnfr12; usefulness in both basic research and as therapeutics |
| 03/15/2007 | US20070060518 Immunogens; plasmids; directly interact with major histocompatability complex, improving immunology |